Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial

著者: Jørgen Vestbo, Julie A. Anderson, Robert D. Brook, Peter M.A. Calverley, Bartolomé R. Celli, Courtney Crim, Fernando J. Martínez, Julie Yates, David E. Newby - The Lancet 2016 被引用: 504